Tamoxifen for nodal recurrence of serous borderline ovarian tumour − a case report
This case highlights the rare phenomenon of late nodal recurrence in borderline ovarian tumours and illustrates the potential role of hormonal therapy in selected cases where surgery is no longer feasible.
Authors
- Reitan Ribeiro (ORCID: https://orcid.org/0000-0002-4323-3854)
- A. Guarneri (ORCID: https://orcid.org/0000-0001-6542-4953)
- Lara Richer (ORCID: https://orcid.org/0000-0002-1150-3610)
- Xing Zeng (ORCID: https://orcid.org/0000-0001-8229-5903)
- Basile Tessier‐Cloutier (ORCID: https://orcid.org/0000-0001-8739-3879)
- Tuyet Nhung Ton Nu
- Lucy Gilbert (ORCID: https://orcid.org/0000-0001-8605-5472)
- Lili Fu (ORCID: https://orcid.org/0000-0003-2261-0902)
- Victoria Mandilaras (ORCID: https://orcid.org/0000-0002-4705-4562)
- Shuk On Annie Leung (ORCID: https://orcid.org/0000-0003-4110-7595)
- Laurence Bernard (ORCID: https://orcid.org/0000-0003-3780-0274)
Institutions
- McGill University Health Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1016/j.gore.2025.101960
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00